Abstract
Background: High-grade B-cell lymphoma (HGBCL), an aggressive variant of B-cell non-Hodgkin lymphoma (NHL), is characterized by several genetic rearrangements. The most frequently detected genes are those involving BCL2 and BCL6 oncogenes. Translocations of these oncogene are linked to a worse clinical outcome. As such, the Immunohistochemistry evaluate the protein over expression of BCL6 and BCL2 which Suggests possible gene rearrangement that need definitive proof of chromosomal rearrangement by Florescence in cito hybridization (FISH). which it makes the diagnosis and prediction of aggressive B-cell lymphomas easier.
Objectives: To evaluate immunohistochemical expression of BCL6 and BCL2 markers in HGBCL cases. Also, to compare their expression with clinicopathological parameters.
Materials and methods: This study is retrospective case series analysis, conducted on 70 cases of HGBCL, collected between Sept. 2024 and Feb. 2025. Immunohistochemical stain was employed to assess the expression of BCL6 and BCL2 markers. Also, CD20 in conjunction with CD3 were done for all cases to approve their B-cell origin.
Results: Out of 70 HGBCL patients, BCL6 protein expression was detected in (64%) of cases, while BCL2 protein was expressed in (83%) of them. The study revealed a male predominance of BCL6 cases, whereas BCL2 has equal occurrence in both genders.
Conclusion: The immunohistochemistry assessment of BCL6 and BCL2 expression, shows significant expression according to the type of lymphoma (p ≤ 0.001). BCL2 positivity was significantly associated with nodal disease with equal sex predominance, while BCL6 expression showed slight male predominance with significant association with nodal disease too.
First Page
1
Last Page
8
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Recommended Citation
Hanna, Raghad Salem; Al-Omar, Zahraa Marwan; and Fadhil, Mustafa Salah
(2026)
"Evaluation of Immunohistochemical Expression of BCL6 and BCL2 in High Grade B-Cell Lymphoma in Nineveh Province,"
BioMed Visions Journal: Vol. 3:
Iss.
1, Article 1.
DOI: https://doi.org/10.63100/3078-6738.1031